Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
2.590
-0.110 (-4.07%)
Nov 20, 2024, 4:00 PM EST - Market closed
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $99.10 million as of November 21, 2024. Its market cap has increased by 125.38% in one year.
Market Cap
99.10M
Enterprise Value
36.66M
1-Year Change
125.38%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has increased from $73.83M to $99.10M, an increase of 34.24%. That is a compound annual growth rate of 3.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 111.90M |
| Fennec Pharmaceuticals | 110.69M |
| Eupraxia Pharmaceuticals | 109.04M |
| Adlai Nortye | 108.86M |
| INmune Bio | 107.98M |
| Inovio Pharmaceuticals | 106.36M |
| Century Therapeutics | 106.29M |
| Tiziana Life Sciences | 105.54M |